Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Mikhailidis, DP; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, A; Athyros, V; de Graaf, J; März, W; Parhofer, KG; Rini, GB; Spinas, GA; Tomkin, GH; Tselepis, AD; Wierzbicki, AS; Winkler, K; Florentin, M; Liberopoulos, E.
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.
Curr Vasc Pharmacol. 2011; 9(5):533-571
Doi: 10.2174/157016111796642661
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
März Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Aim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density liproproteins (LDL) subclasses. We sub-divided our statement in 2 sections. section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drug and lifestyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Atherosclerosis - blood
-
Atherosclerosis - drug therapy
-
Atherosclerosis - epidemiology
-
Atherosclerosis - etiology
-
Atherosclerosis - genetics
-
Genetic Predisposition to Disease -
-
Humans -
-
Lipoproteins, LDL - blood
-
Lipoproteins, LDL - classification
-
Lipoproteins, LDL - genetics
-
Risk Factors -
- Find related publications in this database (Keywords)
-
LDL
-
subclasses
-
atherosclerosis
-
cardiovascular risk
-
statement